GlassScriptPhysician profile
William C Gewin
NPI 1386692267
$2,635.72
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $914 · 2021: $295.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $591.81 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $422.43 | 2019-2021 | |
| Grifols USA, LLC | $276.63 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $262.92 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.89 | 2019-2021 | |
| Electromed, INC. | $184.09 | 2019-2021 | |
| Philips North America LLC | $135.69 | 2019-2020 | |
| Genentech USA, INC. | $82.96 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $66.90 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $62.00 | 2019 | |
| Genzyme Corporation | $61.10 | 2019-2020 | |
| United Therapeutics Corporation | $46.33 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $46.10 | 2020 | |
| Mylan Specialty L.P. | $33.73 | 2019-2020 | |
| Pfizer INC. | $31.44 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $21.21 | 2020 | |
| Merck Sharp & Dohme LLC | $16.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.51 | 2019 | |
| Circassia INC. | $11.40 | 2019 | |
| Novo Nordisk INC | $11.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gewin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.